Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Birkmeyer

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Annals of Internal Medicine|November 30, 1999
The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitorsL Golan, J D Birkmeyer, H G Welch
The American Journal of Medicine|September 1, 1992
Estimates of risk of posttransfusion hepatitisJ D Birkmeyer, J P AuBuchon, B Littenberg
The Journal of Urology|February 25, 2000
The effect of hospital volume on mortality and resource use after radical prostatectomyL M Ellison, J A Heaney, J D Birkmeyer
Effective Clinical Practice : ECP|January 6, 2000
Trends in the use of radical prostatectomy for treatment of prostate cancerL M Ellison, J A Heaney, J D Birkmeyer
JAMA|August 4, 1999
Update of cost-effectiveness analysis for solvent-detergent-treated plasmaB R Jackson, J P AuBuchon, J D Birkmeyer
Lancet (London, England)|August 29, 1992
Should patients with Björk-Shiley valves undergo prophylactic replacement?J D Birkmeyer, C A Marrin, G T O'Connor
Effective Clinical Practice : ECP|May 2, 2000
Potential benefits of regionalizing major surgery in Medicare patientsJ D Birkmeyer, F L Lucas, D E Wennberg
Lancet (London, England)|May 13, 1999
Pounds of prevention for ounces of cure: surgery as a preventive strategyD E Wennberg, J D Birkmeyer, F L Lucas
Transfusion|January 1, 1997
Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated bloodJ P AuBuchon, J D Birkmeyer, M P Busch
Surgery|September 20, 2001
Volume standards for high-risk surgical procedures: potential benefits of the Leapfrog initiativeJ D Birkmeyer, E V Finlayson, C M Birkmeyer
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Annals of Internal Medicine|November 30, 1999
The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitorsL Golan, J D Birkmeyer, H G Welch
The American Journal of Medicine|September 1, 1992
Estimates of risk of posttransfusion hepatitisJ D Birkmeyer, J P AuBuchon, B Littenberg
The Journal of Urology|February 25, 2000
The effect of hospital volume on mortality and resource use after radical prostatectomyL M Ellison, J A Heaney, J D Birkmeyer
Effective Clinical Practice : ECP|January 6, 2000
Trends in the use of radical prostatectomy for treatment of prostate cancerL M Ellison, J A Heaney, J D Birkmeyer
JAMA|August 4, 1999
Update of cost-effectiveness analysis for solvent-detergent-treated plasmaB R Jackson, J P AuBuchon, J D Birkmeyer
Lancet (London, England)|August 29, 1992
Should patients with Björk-Shiley valves undergo prophylactic replacement?J D Birkmeyer, C A Marrin, G T O'Connor
Effective Clinical Practice : ECP|May 2, 2000
Potential benefits of regionalizing major surgery in Medicare patientsJ D Birkmeyer, F L Lucas, D E Wennberg
Lancet (London, England)|May 13, 1999
Pounds of prevention for ounces of cure: surgery as a preventive strategyD E Wennberg, J D Birkmeyer, F L Lucas
Transfusion|January 1, 1997
Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated bloodJ P AuBuchon, J D Birkmeyer, M P Busch
Surgery|September 20, 2001
Volume standards for high-risk surgical procedures: potential benefits of the Leapfrog initiativeJ D Birkmeyer, E V Finlayson, C M Birkmeyer
Pageof 8